SG11201400354PA - Template -fixed peptidomimetics as inhibitors of fpr1 - Google Patents

Template -fixed peptidomimetics as inhibitors of fpr1

Info

Publication number
SG11201400354PA
SG11201400354PA SG11201400354PA SG11201400354PA SG11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA
Authority
SG
Singapore
Prior art keywords
fpr1
inhibitors
template
fixed peptidomimetics
peptidomimetics
Prior art date
Application number
SG11201400354PA
Other languages
English (en)
Inventor
Françoise Jung
Daniel Obrecht
Ralf Löwe
Johann Zimmermann
Guillaume Lemercier
Eric Chevalier
Original Assignee
Polyphor Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ag filed Critical Polyphor Ag
Publication of SG11201400354PA publication Critical patent/SG11201400354PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11201400354PA 2011-10-07 2012-10-02 Template -fixed peptidomimetics as inhibitors of fpr1 SG11201400354PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11008121 2011-10-07
PCT/EP2012/069412 WO2013050346A1 (en) 2011-10-07 2012-10-02 Template -fixed peptidomimetics as inhibitors of fpr1

Publications (1)

Publication Number Publication Date
SG11201400354PA true SG11201400354PA (en) 2014-09-26

Family

ID=46970289

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201400354PA SG11201400354PA (en) 2011-10-07 2012-10-02 Template -fixed peptidomimetics as inhibitors of fpr1

Country Status (11)

Country Link
US (1) US9957297B2 (ja)
EP (1) EP2764010B9 (ja)
JP (1) JP6294227B2 (ja)
CN (1) CN103842373B (ja)
AU (2) AU2012320674A1 (ja)
CA (1) CA2848584C (ja)
ES (1) ES2576959T3 (ja)
IL (1) IL231756B (ja)
MX (1) MX349788B (ja)
SG (1) SG11201400354PA (ja)
WO (1) WO2013050346A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101641372B (zh) 2007-02-28 2012-11-28 波利弗尔有限公司 模板固定的肽模拟物
WO2016050360A1 (en) * 2014-09-30 2016-04-07 Polyphor Ag Beta-hairpin peptidomimetics
CN107636007A (zh) * 2015-03-23 2018-01-26 波利弗尔股份公司 β‑发夹肽模拟物
CN109922818B (zh) * 2016-09-06 2024-02-20 主线生物科学公司 Cxcr4拮抗剂及使用方法
CN111909238B (zh) * 2017-06-29 2022-04-08 安徽省农业科学院农产品加工研究所 一种含有Ser-Cys的高锌螯合活性锌螯合肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002247724B2 (en) 2001-02-23 2008-02-07 Polyphor Ltd. Template-fixed peptidomimetics with antimicrobial activity
BRPI0215855B1 (pt) * 2002-08-20 2016-12-13 Polyphor Ltd peptídeos cíclicos ligados à matriz com ação antimicrobiana
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
KR100831633B1 (ko) * 2004-02-04 2008-05-22 포항공과대학교 산학협력단 Fpr 계열 수용체 매개 신호전달에 대하여 길항작용 하는펩티드
ATE520705T1 (de) 2005-05-02 2011-09-15 Polyphor Ltd Farbstoffkonjugate von schablonenfixierten peptidomimetika
CN101641372B (zh) * 2007-02-28 2012-11-28 波利弗尔有限公司 模板固定的肽模拟物
WO2010060479A1 (en) 2008-11-26 2010-06-03 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
WO2010127704A1 (en) 2009-05-07 2010-11-11 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
EP2438047B1 (en) * 2009-06-02 2014-07-30 Nikan Pharmaceuticals, LLC Antagonism of human formyl peptide receptor for treatment of disease
WO2011066869A1 (en) 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics

Also Published As

Publication number Publication date
US9957297B2 (en) 2018-05-01
MX349788B (es) 2017-08-11
NZ621974A (en) 2015-06-26
EP2764010B1 (en) 2016-03-16
WO2013050346A1 (en) 2013-04-11
EP2764010A1 (en) 2014-08-13
ES2576959T3 (es) 2016-07-12
CN103842373A (zh) 2014-06-04
AU2017204122B2 (en) 2019-05-02
IL231756A0 (en) 2014-05-28
JP6294227B2 (ja) 2018-03-14
CN103842373B (zh) 2018-12-21
CA2848584A1 (en) 2013-04-11
AU2012320674A1 (en) 2014-03-20
EP2764010B9 (en) 2017-01-18
IL231756B (en) 2019-06-30
ES2576959T9 (es) 2017-05-29
CA2848584C (en) 2020-03-24
JP2014528958A (ja) 2014-10-30
MX2014003960A (es) 2014-05-14
AU2017204122A1 (en) 2017-07-06
US20140287986A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
HK1257823A1 (zh) 金屬酶抑制劑化合物
HK1198163A1 (en) Metalloenzyme inhibitor compounds
HK1198651A1 (en) Metalloenzyme inhibitor compounds
HK1243175A1 (zh) 標記的hsp90抑製劑的用途
ZA201309561B (en) Novel inhibitor compounds of phosphodiestarase type 10a
ZA201306221B (en) Compounds and compositions as trk inhibitors
EP2723730A4 (en) METALLOENZYMHEMMERVERBINDUNGEN
EP2678018A4 (en) COMBINATION OF CHINESE HEMMER AND USES THEREOF
EP2706852A4 (en) BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS
EP2665724A4 (en) BICYCLIC INHIBITORS OF ALK
EP2874606A4 (en) LIPOSOMAL COMPOSITIONS OF PROTEASOMBARS ON EPOXYKETONE BASE
ZA201206456B (en) Uses of dgati inhibitors
SMT201600001B (it) Imidazopiridazine come inibitori di akt chinasi
ZA201300004B (en) Cyrstalline form of benzylbenzene sglt2 inhibitor
HK1190143A1 (zh) 作為 抑制劑的新型取代的吡啶並吡嗪類化合物
HK1199252A1 (en) Inhibitors of nedd8-activating enzyme nedd8-
ME02167B (me) Piridinil- i pirazinil-metiloksi-aril derivati korisni kao inhibitori tirozin kinaze slezine (syk)
IL231756A0 (en) Peptides with a fixed pattern as 1fpr inhibitors
EP2751117A4 (en) METALLOENZYMHEMMERVERBINDUNGEN
EP2663322A4 (en) NEW USES OF CYCLOPHILIN INHIBITORS
LU91725B1 (en) Novel uses of V-ATPASE inhibitors
GB201104399D0 (en) Novel inhibitors